NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,160 filers reported holding NOVARTIS A G in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $397,776 | +0.9% | 3,905 | 0.0% | 0.29% | +4.6% |
| Q2 2023 | $394,066 | +10.0% | 3,905 | +0.3% | 0.28% | +4.9% |
| Q1 2023 | $358,082 | +4.2% | 3,892 | +2.7% | 0.27% | +0.8% |
| Q4 2022 | $343,731 | +19.4% | 3,789 | 0.0% | 0.26% | +14.2% |
| Q3 2022 | $288,000 | -10.0% | 3,789 | 0.0% | 0.23% | 0.0% |
| Q2 2022 | $320,000 | -4.8% | 3,789 | -1.1% | 0.23% | +22.1% |
| Q1 2022 | $336,000 | +2.8% | 3,832 | +2.5% | 0.19% | +9.2% |
| Q4 2021 | $327,000 | +6.9% | 3,738 | 0.0% | 0.17% | -3.3% |
| Q3 2021 | $306,000 | -10.3% | 3,738 | 0.0% | 0.18% | -5.3% |
| Q2 2021 | $341,000 | +7.2% | 3,738 | +0.3% | 0.19% | -3.1% |
| Q1 2021 | $318,000 | -53.6% | 3,725 | -48.8% | 0.20% | -20.0% |
| Q4 2020 | $686,000 | – | 7,274 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 198,000 | $14,422,000 | 8.45% |
| PRENTISS SMITH & CO INC | 133,202 | $9,702,000 | 5.92% |
| EXENCIAL WEALTH ADVISORS, LLC | 178,313 | $12,988,000 | 5.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 185,868 | $13,538,000 | 5.33% |
| Osher Van de Voorde Investment Management | 114,735 | $8,357,000 | 4.59% |
| BROWN BROTHERS HARRIMAN & CO | 10,971,272 | $799,147,000 | 4.37% |
| PROFESSIONAL ADVISORY SERVICES INC | 238,542 | $17,375,000 | 4.04% |
| Elefante Mark B | 4,579 | $333,000 | 4.02% |
| COMPASS CAPITAL MANAGEMENT, INC | 271,536 | $19,779,000 | 3.69% |
| CGOV Asset Management | 972,731 | $95,135,000 | 3.51% |